DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lawitz E, Makara M, Akarca US. et al.
Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.
Gastroenterology 2015;
149: 971-980.e971
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.